Major Investor Group Sells $190K in Firefly Neuroscience Shares
AIFF is trading near its 52-week low of $0.805 (5.5% above the low) on elevated volume (2.4× avg).
Summary
Windsor Private Capital LP and its affiliates, a significant investor group, sold 185,800 shares of Firefly Neuroscience common stock for approximately $190,600, reducing their collective beneficial ownership to 5.6%.
Key Events · Ownership and Investor Activity · AIFF
-
Significant Share Sales
Windsor Private Capital LP and its affiliated entities sold an aggregate of 185,800 common shares between December 10, 2025, and December 31, 2025.
-
Transaction Value
The sales generated approximately $190,600 in proceeds for the investor group.
-
Reduced Ownership
The investor group's beneficial ownership decreased to 5.6% of Firefly Neuroscience's outstanding common stock.
-
Declining Sale Prices
The shares were sold at prices ranging from $1.71 to $0.87 per share, indicating a downward trend during the selling period.
Analysis · AIFF · Technology
This Schedule 13D/A filing indicates that Windsor Private Capital LP and its associated individuals, a significant investor group, have substantially reduced their stake in Firefly Neuroscience. The sale of 185,800 shares, totaling approximately $190,600, represents a notable divestment for a company with an $11.8 million market capitalization. While the group remains a significant shareholder with 5.6% ownership, this reduction, especially as the stock price declined during the selling period, could be interpreted as a lack of conviction or a move to reallocate capital. Investors should note the continued selling pressure from a major holder.
At the time of this filing, AIFF was trading at $0.85 on NASDAQ in the Technology sector, with a market capitalization of approximately $11.8M. The 52-week trading range was $0.81 to $17.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.